Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

A retrograde step to 30-day packs

I note with dismay the announcement in the PJ that the Femara packaging has been switched from a 28-pack to 30-day pack. (PJ 2014;292:292).

At this time when we should be helping patients with their medicines as part of our medicines optimisation initiatives, I believe this is a retrograde step by Novartis. Moving from a 28-day calendar pack to a 30-day pack will not be of any benefit to patients who may be on this medicine for up to 10 years.

All patient packs should be calendar packs, where appropriate, and should be in multiples of 28. The Royal Pharmaceutical Society should be pressing the Medicines and Healthcare products Regulatory Agency and the manufacturers to switch to 28-day calendar packs.

Hopefully, the generic manufacturers of letrozole will not be following this example.

Peter McAuley


Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.11137456

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.